Xeris Hits Fresh All Time Lows Despite Bullish Investor Update
Jefferies Thinks The Stock Will Be Cash Flow Positive In 2024 Shares of small-cap biotech firm Xeris Biopharma Holdings Inc (NASDAQ:XERS) slipped -1% in trading on Thursday, hitting fresh new lows even with a positive outlook update from management. Ahead of planned meetings with investors next week, management updated its guidance for the full year 2022 results. Q4 2022 hedge fund letters, conferences and more Find A Qualified Financial AdvisorEach advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you're ready to be matched with local ...